SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-97-003384
Filing Date
1997-08-12
Accepted
1997-08-12 00:00:00
Documents
12
Period of Report
1997-06-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS 2ND QUARTER REPORT 10-Q 39812
2 AMENDED EMPLOYMENT AGREEMENT WITH HARVEY BERGER EX-10.29 3485
3 AMENDED EMPLOYMENT AGREEMENT WITH JAY LAMARCHE EX-10.30 8852
4 AMENDED EMPLOYMENT AGREEMENT WITH CHARLES CABOT EX-10.31 8820
5 AMENDED EMPLOYMENT AGREEMENT WITH MANFRED WEIGELE EX-10.32 8928
6 AMENDED EMPLOYMENT AGREEMENT WITH MICHAEL GILMAN EX-10.33 9095
7 CONSULTING AGREEMENT FOR MEMBERS EX-10.34 18792
8 1997 EMPLOYEE STOCK PURCHASE PLAN EX-10.35 30565
9 AMENDMENT TO 1991 STOCK OPTION PLAN EX-10.36 1580
10 AMENDMENT TO 1994 STOCK OPTION PLAN NON-EMPLOYEE EX-10.37 1392
11 FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-10.38 33273
12 FINANCIAL DATA SCHEDULE EX-27 2150
  Complete submission text file 0000950135-97-003384.txt   169528
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21696 | Film No.: 97656863
SIC: 2836 Biological Products, (No Diagnostic Substances)